These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 15562437
1. NAD+ as a metabolic link between DNA damage and cell death. Ying W, Alano CC, Garnier P, Swanson RA. J Neurosci Res; ; 79(1-2):216-23. PubMed ID: 15562437 [Abstract] [Full Text] [Related]
2. NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Ying W, Garnier P, Swanson RA. Biochem Biophys Res Commun; 2003 Sep 05; 308(4):809-13. PubMed ID: 12927790 [Abstract] [Full Text] [Related]
3. Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity. Tang KS, Suh SW, Alano CC, Shao Z, Hunt WT, Swanson RA, Anderson CM. Glia; 2010 Mar 05; 58(4):446-57. PubMed ID: 19795500 [Abstract] [Full Text] [Related]
4. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Ying W, Sevigny MB, Chen Y, Swanson RA. Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):12227-32. PubMed ID: 11593040 [Abstract] [Full Text] [Related]
5. Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. Ying W, Chen Y, Alano CC, Swanson RA. J Cereb Blood Flow Metab; 2002 Jul 09; 22(7):774-9. PubMed ID: 12142562 [Abstract] [Full Text] [Related]
6. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Affar el B, Shah RG, Dallaire AK, Castonguay V, Shah GM. Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):245-50. PubMed ID: 11756665 [Abstract] [Full Text] [Related]
7. Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake. Suzuki E, Okuda H, Nishida K, Fujimoto S, Nagasawa K. Life Sci; 2010 Apr 24; 86(17-18):676-82. PubMed ID: 20188745 [Abstract] [Full Text] [Related]
8. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, Poirier GG, Dawson VL, Dawson TM. Proc Natl Acad Sci U S A; 2014 Jul 15; 111(28):10209-14. PubMed ID: 24987120 [Abstract] [Full Text] [Related]
9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. J Pharmacol Exp Ther; 2004 Aug 15; 310(2):425-36. PubMed ID: 15075382 [Abstract] [Full Text] [Related]
10. NADH can enter into astrocytes and block poly(ADP-ribose) polymerase-1-mediated astrocyte death. Zhu K, Swanson RA, Ying W. Neuroreport; 2005 Aug 01; 16(11):1209-12. PubMed ID: 16012350 [Abstract] [Full Text] [Related]
12. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. J Cereb Blood Flow Metab; 1997 Nov 01; 17(11):1143-51. PubMed ID: 9390645 [Abstract] [Full Text] [Related]
13. NAD(+) influx through connexin hemichannels prevents poly(ADP-ribose) polymerase-mediated astrocyte death. Okuda H, Nishida K, Higashi Y, Nagasawa K. Life Sci; 2013 Apr 19; 92(13):808-14. PubMed ID: 23454167 [Abstract] [Full Text] [Related]
14. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage. Rancourt A, Satoh MS. DNA Repair (Amst); 2009 Mar 01; 8(3):286-97. PubMed ID: 19144573 [Abstract] [Full Text] [Related]
15. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ, Bourgeois M, Harbison RD. Cardiovasc Toxicol; 2018 Dec 01; 18(6):493-506. PubMed ID: 29968072 [Abstract] [Full Text] [Related]
16. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase. Zhang J, Lautar S, Huang S, Ramsey C, Cheung A, Li JH. Biochem Biophys Res Commun; 2000 Nov 30; 278(3):590-8. PubMed ID: 11095954 [Abstract] [Full Text] [Related]
17. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects. Pogrebniak A, Schemainda I, Pelka-Fleischer R, Nüssler V, Hasmann M. Eur J Med Res; 2003 Oct 22; 8(10):438-50. PubMed ID: 14594650 [Abstract] [Full Text] [Related]
19. The role of poly(ADP-ribose) polymerase-1 in CNS disease. Kauppinen TM, Swanson RA. Neuroscience; 2007 Apr 14; 145(4):1267-72. PubMed ID: 17084037 [Abstract] [Full Text] [Related]
20. PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors. Gerace E, Masi A, Resta F, Felici R, Landucci E, Mello T, Pellegrini-Giampietro DE, Mannaioni G, Moroni F. Neurobiol Dis; 2014 Oct 14; 70():43-52. PubMed ID: 24954469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]